CT-526 Updated Results from a Rapcabtagene Autoleucel (YTB323) Phase I Study Demonstrate Durable Efficacy and a Manageable Safety Profile in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Nirav N. Shah, Ian W. Flinn, Mi Kwon, Ulrich Jäger, Javier Briones, Emmanuel Bachy,Didier Blaise, Nicolas Boissel,Koji Kato, Peter A. Riedell, Matthew J. Frigault,Leyla Shune,Takanori Teshima,Fabio Ciceri, Shaun Fleming, Silvia Ferrari,David Pearson, Jeanne Whalen,Aiesha Zia,Jaclyn Davis,Aisha Masood, Michael Dickinson, Pere Barba

Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia（2023）

引用 0|浏览0

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要